Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)

NCT05186948 is registered in ClinicalTrials.gov with Innodem Neurosciences as lead sponsor.

NCT NCT05186948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05186948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
Lead sponsor
Innodem Neurosciences
Phase
Observational
Overall status
Terminated
Start date
March 30, 2022
Completion date
January 20, 2025
Enrollment
230 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related cognitive impairment